Arbor Research
 

Arbor Research Collaborative for Health News 

 
February 2015
In This Issue
Leichtman and Pozniak Join Arbor Research

Arbor Research is proud to announce the addition of two research scientists to our growing team.

 

Dr. Leichtman, MD, will make important contributions to Arbor Research projects, including the Dialysis Outcomes and Practice Pattern Study (DOPPS) and a Food and Drug Administration (FDA) sponsored study to evaluate patient acceptance of generic immunosuppressive medications. Learn more about Dr. Leichtman here.

 

Dr. Pozniak, PhD, will contribute to both new and existing projects within the Arbor Research Health Policy and Practice Program, including projects under the Centers for Medicare & Medicaid Services (CMS) Research, Measurement, Assessment, Design, and Analysis (RMADA) contract vehicle. Learn more about Dr. Pozniak here.


We're Hiring! 

curly-table-woman.jpg

Arbor Research offers challenging and rewarding opportunities for highly skilled, intellectual, and dedicated individuals who share our commitment to improving patients' lives. Our current openings include, but are not limited to, Data Management, Research Analysts, and Project Management.

 

To view the full list of openings, please visit our Careers page.

 

 


 

 

Join Our Mailing List

 

Like us on Facebook    View our profile on LinkedIn    Follow us on Twitter

 

Tel: +1 (734) 665-4108

            


 

            


 

 
 
We are pleased to share news about our projects and publications with you. We appreciate your interest in our work to improve patient care through research that shapes medical policies and practice.

New Research on Parathyroid Hormone Levels

  

DOPPS researchers, led by Dr. Francesca Tentori, recently published findings on outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis in the Clinical Journal of the American Society of Nephrology. Click here to hear Dr. Tentori discuss these findings  


DOPPS Publishes Guidance on Research Methods

 

The instrumental variable approach is a statistical methodology that has been widely used in medical research. It has served as the cornerstone of many of the Dialysis Outcomes and Practice Patterns Study (DOPPS) research papers.

 

DOPPS researchers, led by Dr. Yun Li, have published new findings regarding the use of this approach in reducing the impact of unmeasured confounding in the journal Statistics in Medicine. Click here to learn more about this publication.  


DPM Data Highlight Trends in Dialysis Care
                       

The DOPPS Practice Monitor (DPM) now includes over four years of trends in US dialysis care, including comparisons by race, rural location, and affiliated chain size. Recent additions to the DPM include additional data from electronic medical records and facility-level variation in risks of transfusion and hospitalization recorded in Medicare claims data. Click here to learn more about DPM data and findings.


                    
List of Key Studies Includes Paper by Arbor Research Investigator

In celebration of 20 years of The American Journal of Managed Care, the journal is taking a look back at some of the most influential studies that have appeared since its inception. Research led by Arbor Research Senior Research Scientist Teresa Gibson is highlighted in this retrospective. Please click here to learn more.

  

A2ALL Models

Spleen Volume after

Living Liver Donation

 

Among adults who donate a portion of their liver for transplantation, clinical studies have drawn attention to persistently decreased platelet counts. Researchers with the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) wanted to know whether low platelet counts caused enlarged spleens after liver donation. Click here to learn more about these findings

 


 

On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication. Li Y, et al; Statistics in Medicine. Click to view abstract.

 

Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality. Bailie GR, et al; Kidney International. Click to view abstract.